Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 10, 2022 · 10-K · 69 days after period end · 0001564590-22-009485
| Metric | Q4 2021 | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Net Income | -$7.15M | -$4.72M | -$3.19M | -$3.64M |
| EPS Diluted | -$0.76 | -$1.11 | -$5.91 | -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 10, 2022 · 69 d after period end
